2017
ASSOCIATION BETWEEN THE VITREOMACULAR INTERFACE AND OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS IN WET AGE-RELATED MACULAR DEGENERATION
Ashraf M, Souka A, Adelman RA. ASSOCIATION BETWEEN THE VITREOMACULAR INTERFACE AND OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS IN WET AGE-RELATED MACULAR DEGENERATION. Retina 2017, 37: 1738-1745. PMID: 28005632, DOI: 10.1097/iae.0000000000001423.Peer-Reviewed Original ResearchConceptsType 1 choroidal neovascularizationChoroidal thicknessChoroidal neovascularizationWet AMDVitreomacular adhesionDry AMDVitreomacular interfaceMacular degenerationRetrospective observational cross-sectional studyOptical coherence tomography examinationObservational cross-sectional studyAge-related macular degenerationType of CNVPaired-eye studyMean choroidal thicknessCross-sectional studySignificant differencesOptical coherence tomographyWet AgeSubgroup analysisTomography examinationHeidelberg SpectralisPatientsCoherence tomographyDegeneration characteristic
2014
Cataract formation following vitreoretinal procedures
Feng H, Adelman RA. Cataract formation following vitreoretinal procedures. Clinical Ophthalmology 2014, Volume 8: 1957-1965. PMID: 25284982, PMCID: PMC4181740, DOI: 10.2147/opth.s68661.Peer-Reviewed Original ResearchPars plana vitrectomyScleral bucklePneumatic retinopexyVitreoretinal proceduresPostoperative cataractCataract extractionGauge pars plana vitrectomySmall-gauge pars plana vitrectomyYale Eye CenterRetrospective observational studyMain outcome measuresNuclear sclerotic cataractPercentage of eyesSignificant differencesLens statusSurgical eyesPostoperative dataConsecutive patientsPlana vitrectomyIntraocular surgeryMedical recordsObservational studyInclusion criteriaOutcome measuresEye Center
2013
Strategy for the Management of Complex Retinal Detachments The European Vitreo-Retinal Society Retinal Detachment Study Report 2
Adelman RA, Parnes AJ, Sipperley JO, Ducournau D, Group E. Strategy for the Management of Complex Retinal Detachments The European Vitreo-Retinal Society Retinal Detachment Study Report 2. Ophthalmology 2013, 120: 1809-1813. PMID: 23601805, DOI: 10.1016/j.ophtha.2013.01.056.Peer-Reviewed Original ResearchConceptsRhegmatogenous retinal detachmentGiant retinal tearsRetinal detachmentScleral buckleComplex retinal detachmentChoroidal detachmentRetinal tearsGrade CGrade B proliferative vitreoretinopathyLow failure rateComplex rhegmatogenous retinal detachmentRetinal detachment repairFailure rateProcedure of choiceSignificant differencesMethod of repairSignificant hypotonyClinical manifestationsDetachment repairGiant tearsRetrospective studyMacular holePrimary procedureProliferative vitreoretinopathyLarge tearsStrategy for the Management of Uncomplicated Retinal Detachments The European Vitreo-Retinal Society Retinal Detachment Study Report 1
Adelman RA, Parnes AJ, Ducournau D, Group E. Strategy for the Management of Uncomplicated Retinal Detachments The European Vitreo-Retinal Society Retinal Detachment Study Report 1. Ophthalmology 2013, 120: 1804-1808. PMID: 23601799, DOI: 10.1016/j.ophtha.2013.01.070.Peer-Reviewed Original ResearchConceptsRhegmatogenous retinal detachmentUncomplicated rhegmatogenous retinal detachmentScleral buckle groupRetinal detachmentScleral buckleFinal failure rateSingle-surgery reattachment rateCases of RRDBenefit of vitrectomyMulticenter retrospective studyRetinal detachment repairUncomplicated retinal detachmentsSpecific clinical findingsFailure ratePhakic retinal detachmentSignificant differencesMethod of repairAphakic groupPhakic patientsVitrectomy groupUncomplicated casesClinical findingsDetachment repairPseudophakic patientsReattachment rate
2009
ASSESSMENT OF OPTIC NERVE CUP-TO-DISK RATIO CHANGES IN PATIENTS RECEIVING MULTIPLE INTRAVITREAL INJECTIONS OF ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS
SETH RK, SALIM S, SHIELDS MB, ADELMAN RA. ASSESSMENT OF OPTIC NERVE CUP-TO-DISK RATIO CHANGES IN PATIENTS RECEIVING MULTIPLE INTRAVITREAL INJECTIONS OF ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS. Retina 2009, 29: 956-959. PMID: 19584654, DOI: 10.1097/iae.0b013e3181a91dfd.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAptamers, NucleotideDrug Therapy, CombinationEyeFollow-Up StudiesFundus OculiHumansInjectionsIntraocular PressureOptic DiskOptic NerveRanibizumabRegional Blood FlowRetrospective StudiesSingle-Blind MethodVascular Endothelial Growth Factor AVitreous BodyConceptsMultiple intravitreal injectionsAnti-VEGF agentsIntraocular pressure riseIntraocular pressure fluctuationIntravitreal injectionMean changeControl groupTransient intraocular pressure riseSignificant differencesDisc ratio changesOptic nerve cupHistory of glaucomaAdditional prospective studiesGrowth factor effectsFellow eyesGlaucoma specialistsOptic nerveProspective studyOptic disc imagesFundus photographsTriamcinolone acetonideInclusion criteriaDisc ratioVertical cupPatients